Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Resveratrol oligomers are potent MRP1 transport inhibitors.

Bobrowska-Hägerstrand M, Lillås M, Mrówczyñska L, Wróbel A, Shirataki Y, Motohashi N, Hägerstrand H.

Anticancer Res. 2006 May-Jun;26(3A):2081-4.

2.

Inhibition of MRP1-mediated efflux in human erythrocytes by mono-anionic bile salts.

Mrówczynska L, Bobrowska-Hägerstrand M, Wróbel A, Söderström T, Hägerstrand H.

Anticancer Res. 2005 Sep-Oct;25(5):3173-8.

3.

Flow cytometric monitoring of multidrug drug resistance protein 1 (MRP1/ABCC1) -mediated transport of 2',7'-bis-(3-carboxypropyl)-5-(and-6)- carboxyfluorescein (BCPCF) into human erythrocyte membrane inside-out vesicles.

Bobrowska-Hägerstrand M, Wróbel A, Rychlik B, Ohman I, Hägerstrand H.

Mol Membr Biol. 2007 Sep-Dec;24(5-6):485-95. Erratum in: Mol Membr Biol. 2008 Feb;25(2):178.

PMID:
17710652
4.

Flavonoids as inhibitors of MRP1-like efflux activity in human erythrocytes. A structure-activity relationship study.

Bobrowska-Hägerstrand M, Wróbel A, Mrówczyńska L, Söderström T, Shirataki Y, Motohashi N, Molnár J, Michalak K, Hägerstrand H.

Oncol Res. 2003;13(11):463-9.

PMID:
12812360
5.

Monitoring of MRP-like activity in human erythrocytes: inhibitory effect of isoflavones.

Bobrowska-Hägerstrand M, Wróbel A, Rychlik B, Bartosz G, Söderström T, Shirataki Y, Motohashi N, Molnár J, Michalak K, Hägerstrand H.

Blood Cells Mol Dis. 2001 Sep-Oct;27(5):894-900.

PMID:
11783953
6.

Modulation of MRP1-like efflux activity in human erythrocytes caused by membrane perturbing agents.

Bobrowska-Hägerstrand M, Wróbel A, Mrówczyńska L, Söderström T, Hägerstrand H.

Mol Membr Biol. 2003 Jul-Sep;20(3):255-9.

PMID:
12893533
7.

Lignans and norlignans inhibit multidrug resistance protein 1 (MRP1/ABCC1)-mediated transport.

Wróbel A, Eklund P, Bobrowska-Hägerstrand M, Hägerstrand H.

Anticancer Res. 2010 Nov;30(11):4423-8.

PMID:
21115888
8.

Phenothiazine maleates stimulate MRP1 transport activity in human erythrocytes.

Wesołowska O, Mosiadz D, Motohashi N, Kawase M, Michalak K.

Biochim Biophys Acta. 2005 Dec 30;1720(1-2):52-8. Epub 2005 Dec 6.

10.
11.
12.

Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).

He SM, Li R, Kanwar JR, Zhou SF.

Curr Med Chem. 2011;18(3):439-81. Review.

PMID:
21143116
13.

Modulation of MRP1 protein transport by plant, and synthetically modified flavonoids.

Łania-Pietrzak B, Michalak K, Hendrich AB, Mosiadz D, Grynkiewicz G, Motohashi N, Shirataki Y.

Life Sci. 2005 Aug 26;77(15):1879-91.

PMID:
15916776
14.

Inhibition of the multidrug resistance protein 1 (MRP1) by peptidomimetic glutathione-conjugate analogs.

Burg D, Wielinga P, Zelcer N, Saeki T, Mulder GJ, Borst P.

Mol Pharmacol. 2002 Nov;62(5):1160-6.

15.

Cytotoxic and antimutagenic stilbenes from seeds of Paeonia lactiflora.

Kim HJ, Chang EJ, Bae SJ, Shim SM, Park HD, Rhee CH, Park JH, Choi SW.

Arch Pharm Res. 2002 Jun;25(3):293-9.

PMID:
12135100
17.

Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes.

Wu CP, Klokouzas A, Hladky SB, Ambudkar SV, Barrand MA.

Biochem Pharmacol. 2005 Aug 15;70(4):500-10.

18.

The role of multidrug resistance protein 1 (MRP1) in transport of fluorescent anions across the human erythrocyte membrane.

Rychlik B, Balcerczyk A, Klimczak A, Bartosz G.

J Membr Biol. 2003 May 15;193(2):79-90.

PMID:
12879156
19.

Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1).

Dekkers DW, Comfurius P, Schroit AJ, Bevers EM, Zwaal RF.

Biochemistry. 1998 Oct 20;37(42):14833-7.

PMID:
9778357
20.

Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport.

Evers R, Kool M, Smith AJ, van Deemter L, de Haas M, Borst P.

Br J Cancer. 2000 Aug;83(3):366-74.

Supplemental Content

Support Center